Cross-Protection of Inactivated Rabies Vaccines for Veterinary Use against Bat Lyssaviruses Occurring in Europe. [PDF]
Servat A, Wasniewski M, Cliquet F.
europepmc +1 more source
New human rabies vaccines in the pipeline.
Fooks AR, Banyard AC, Ertl HCJ.
europepmc +1 more source
Oral Rabies Vaccines – Background in terms of historical development, technical specifications, current production situation, research updates [PDF]
Müller, Thomas, Freuling, Conrad Martin
core
Cost-utility analysis of pre-exposure prophylaxis rabies vaccine in 5-year-old children in Thailand. [PDF]
Soopairin S +5 more
europepmc +1 more source
A novel double-mAb sandwich ELISA utilizing broad-spectrum neutralizing antibodies as an <i>in vitro</i> alternative to the rabies vaccine NIH potency assay. [PDF]
Cai M +12 more
europepmc +1 more source
Development and Characterization of Pseudotype-based Microneutralization Assay to Assess Functionality of Anti-rabies Protein G Antibodies. [PDF]
R A +10 more
europepmc +1 more source
SYN023, a Humanized Monoclonal Antibody Cocktail, Broadly Neutralizes Genetically Diverse Lyssaviruses and Validates Epitope Prediction Accuracy. [PDF]
Qu J +6 more
europepmc +1 more source
Compliance with Two Vaccination Regimens of Freeze-Dried Human Rabies Vaccine (Vero Cell) and Influencing Factors in Hubei Province, China. [PDF]
Li D +17 more
europepmc +1 more source
A Recombinant RABV-G-Based Chemiluminescence Immunoassay for Quantitative Detection of Rabies Virus Antibodies. [PDF]
Zhang Y +5 more
europepmc +1 more source

